US FDA’s Amy Abernethy Leaves Behind Legacy Of Tech Modernization, Real-World Data

 
• By Sue Sutter
  
Amy Abernethy 2020
Amy Abernethy will depart the FDA in April after more than two years as principal deputy commissioner. • Source: FDA
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Real-World Evidence

More from Clinical Trials